Illumina Inc. (ILMN)
Health Care1 article
Price chart
Why is ILMN moving today?
-2.0%ILMN is -2.0% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
Illumina Inc. (ILMN) overview
Illumina is the leading maker of DNA-sequencing systems.
ILMN is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.
Illumina Inc. trades on the NasdaqGS under the ticker symbol ILMN. The most recent market data puts the share price at about $262.54. That is down 2.01% on the session. At that price the company is worth roughly $39.64B.
Over the past 52 weeks, ILMN has traded between $94.00 and $309.35. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 49.0. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch ILMN
ILMN is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each ILMN story as it breaks, and tags it bullish, bearish or neutral.
What moves ILMN
- Earnings. ILMN reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from ILMN.
- Sector news. Health Care stocks often move together, so a rival's news can move ILMN too.
Market Mood
Latest ILMN news
Illumina (ILMN) Form 144 Filed on June 5, Details Pending
Illumina (ILMN) filed Form 144 on June 5. This form typically indicates a proposed sale of shares by insiders. The filing could suggest potential stock sales in the market, which might influence investor sentiment. Details regarding the volume or price of the shares involved were not disclosed in the filing. Such filings are crucial as they provide insights into insider trading activity.
Read More: Illumina (ILMN) Form 144 Filed on June 5, Details PendingMore Health Care stocks
Frequently asked questions
Is Illumina Inc. in the S&P 500?
Yes. Illumina Inc. trades as ILMN and is a member of the S&P 500. The index lists it in the Health Care sector.
What sector is ILMN in?
ILMN sits in the Health Care sector of the S&P 500.
Where can I find the latest ILMN news?
Right here. This page collects recent ILMN news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is Illumina Inc.'s stock price?
ILMN last traded at about $262.54. Prices move all through the session, so this is the latest quote rather than a live one.
What is Illumina Inc.'s market cap?
ILMN is worth roughly $39.64B. Market cap is the share price times the number of shares outstanding.
What is ILMN's P/E ratio?
ILMN trades at a trailing P/E ratio of about 49.0. The ratio compares the share price with earnings per share over the past year.